Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 7.32%, which has investors questioning if this is right time to buy.

Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 12.39%, which has investors questioning if this is right time ...

Lexicon Pharmaceuticals had a negative return on equity of 107.38% and a negative net margin of 4,109.41%. On average, equities analysts anticipate that Lexicon Pharmaceuticals will post -0.66 EPS ...

Latest data shows the largest indicative borrow rate increases among liquid option names include: NEWSMAX INC (NMAX) 328.49% +45.34, ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Phathom Pharmaceuticals (PHAT – Research ...

At close: 31 March at 16:00:01 GMT-4 ...

No government wants to implement austerity but some find they have no choice. If the Coalition finds itself in a position ...

As U.S. markets navigate the complexities of tariff negotiations and economic uncertainty, investors are keeping a close eye on potential opportunities within various sectors. Penny stocks, often ...

Healthcare & Pharmaceuticalscategory· April 7, 2025 Rhythm Pharma's drug for rare obesity meets late-stage trial goal Rhythm Pharmaceuticals said on Monday its drug Imcivree notably reduced ...